News from Penumbra Inc.
June 23, 2022
ALAMEDA, Calif.–Penumbra Inc. (NYSE: PEN) shared that its latest RED Reperfusion Catheters received approval from Health Canada, expanding on the company’s extensive portfolio of innovative stroke products in Canada. The RED Catheters are designed with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood clots in acute ischemic stroke patients with large vessel occlusions.
“The RED series of catheters build on our previous design generations, continuing our efforts to maximize both trackability and aspiration efficiency,” said Sandra Lesenfants, president of interventional at Penumbra, Inc. “The RED series catheters will provide physicians in Canada with the broadest portfolio of aspiration thrombectomy solutions for stroke management.”
Contact
Parinaz Farzin
Merryman Communications
parinaz@merrymancommunications.com
310.600.6746
